Puma Biotechnology, Inc. Forecast, price target & analysts
Puma Biotechnology, Inc. Target price 2026 - Analyst rating & recommendation
Puma Biotechnology, Inc. Classifications & Recommendation
Puma Biotechnology, Inc. Price Target
| Target Price | $5.10 |
| Price | $9.67 |
| Deviation |
47.26%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Puma Biotechnology, Inc. 2027 .
The average Puma Biotechnology, Inc. target price is $5.10.
This is
47.26%
register free of charge
$5.25
45.71%
register free of charge
$5.05
47.78%
register free of charge
|
|
| A rating was issued by 6 analysts: 0 Analysts recommend Puma Biotechnology, Inc. to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Puma Biotechnology, Inc. stock has an average upside potential 2027 of
47.26%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 228.37 | 226.44 |
| 0.91% | 0.85% | |
| EBITDA Margin | 21.12% | 18.92% |
| 14.58% | 10.43% | |
| Net Margin | 13.62% | 6.68% |
| 3.69% | 50.96% |
3 Analysts have issued a sales forecast Puma Biotechnology, Inc. 2026 . The average Puma Biotechnology, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Puma Biotechnology, Inc. EBITDA forecast 2026. The average Puma Biotechnology, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Puma Biotechnology, Inc. Analysts have issued a net profit forecast 2026. The average Puma Biotechnology, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.61 | 0.30 |
| 1.61% | 50.82% | |
| P/E | 32.15 | |
| EV/Sales | 1.75 |
3 Analysts have issued a Puma Biotechnology, Inc. forecast for earnings per share. The average Puma Biotechnology, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Puma Biotechnology, Inc....
Current Puma Biotechnology, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Feb 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 23 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 20 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 08 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Feb 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 23 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 20 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 08 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
